医学文献 >>
  • 检索发现
  • 增强检索
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
默认
×
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

MRI-derived radiomics models for diagnosis,aggressiveness,and prognosis evaluation in prostate cancer

摘要Prostate cancer(PCa)is a pernicious tumor with high heterogeneity,which creates a conundrum for making a precise diagnosis and choosing an optimal treatment approach.Multiparametric magnetic resonance imaging(mp-MRI)with anatomical and functional sequences has evolved as a routine and significant paradigm for the detection and characterization of PCa.Moreover,using radiomics to extract quantitative data has emerged as a promising field due to the rapid growth of artificial intelligence(AI)and image data processing.Radiomics acquires novel imaging biomarkers by extracting imaging signatures and establishes models for precise evaluation.Radiomics models provide a reliable and noninvasive alternative to aid in precision medicine,demonstrating advantages over traditional models based on clinicopathological parameters.The purpose of this review is to provide an overview of related studies of radiomics in PCa,specifically around the development and validation of radiomics models using MRI-derived image features.The current landscape of the literature,focusing mainly on PCa detection,aggressiveness,and prognosis evaluation,is reviewed and summarized.Rather than studies that exclusively focus on image biomarker identification and method optimization,models with high potential for universal clinical implementation are identified.Furthermore,we delve deeper into the critical concerns that can be addressed by different models and the obstacles that may arise in a clinical scenario.This review will encourage researchers to design models based on actual clinical needs,as well as assist urologists in gaining a better understanding of the promising results yielded by radiomics.

更多
广告
作者 Xuehua ZHU [1] Lizhi SHAO [2] Zhenyu LIU [3] Zenan LIU [1] Jide HE [1] Jiangang LIU [4] Hao PING [5] Jian LU [1] 学术成果认领
作者单位 Department of Urology,Peking University Third Hospital,Beijing 100191,China [1] CAS Key Laboratory of Molecular Imaging,Institute of Automation,Chinese Academy of Sciences,Beijing 100190,China [2] CAS Key Laboratory of Molecular Imaging,Institute of Automation,Chinese Academy of Sciences,Beijing 100190,China;School of Artificial Intelligence,University of Chinese Academy of Sciences,Beijing 100080,China [3] Beijing Advanced Innovation Center for Big Data-Based Precision Medicine,School of Engineering Medicine,Beihang University,Beijing 100191,China;Key Laboratory of Big Data-Based Precision Medicine(Beihang University),Ministry of Industry and Information Technology of the People's Republic of China,Beijing 100191,China [4] Department of Urology,Beijing Tongren Hospital,Capital Medical University,Beijing 100730,China [5]
栏目名称
DOI 10.1631/jzus.B2200619
发布时间 2023-09-26(万方平台首次上网日期,不代表论文的发表时间)
提交
  • 浏览15
  • 下载3
浙江大学学报(英文版)(B辑:生物医学和生物技术)

加载中!

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

法律状态公告日 法律状态 法律状态信息

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new医文AI 翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷